2Kornegay J R, Roger M, Davies PO, et al. Intonational proficiency study of a consensus L1 PCR assay for the detection and typing of human papillomavirus-DNA:evaluation of accuracy and intralaboratory and interlaboratory agreement. J Clin Microbiol, 2002, 41 (3) :1080 - 1086.
3An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus(HPV) genotypes detected with the HPV DNA chip microarray method. Cancer,2003,97 ( 7 ) : 1672 - 1680.
4Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus typeS in invasive cervical cancer worldwide : a meta-analysis. Br J Cancer, 2003,88 ( 1 ) : 63 - 73.
5Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shah we vaccinate and screen? The international perspective, Int J Cancer, 2004,111 (2) : 278 - 285.
6Munoz N, Bosch FX, Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003,348 (6) :518 -527.
7Einstein MH, Goldberg GL. Human papillomavirus and cervical neoplasia. Cancer Invest, 2002,20 (7 - 8) :1080 - 1085.
8Kim C J, Jeong J K, Park M, et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol, 2003,89 (2) :210 -217.
9LO KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer, 2002,100 (3) : 327 - 331.
5[2]Anttila A, Pukkala E, Sderman B, et al.Effect of organized screening on cervical cancer incidence and mortality in Finland, 1963-1995: Recent increase in cervical cancer incidence.Int J Cancer, 1999,83:59-65.
6[3]Walboomers JM, Jacobs MV, Manos MM, et al.Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol, 1999, 189:12-19.
7[4]Bosch FX, Manos MM, Munoz N, et al.Prevalence of Human Papillomavirus in cervical cancer: a World Perspective.J of the National Cancer Inst, 1995, 87: 796-802.
8[5]Clifford GM,Smith JS,Plummer M,et al.Human papillomavirus types in invasive cancer worldwide:a meta-analysis.Br J cancer,2003,88:63-73.
9[6]Biedermann K, Dandachi N, Trattner M, et al. Comparison of Real-Time PCR Signal-Amplified In Situ Hybridization and Conventional PCR for Detection and Quantification of Human Papillomavirus in Archival Cervical Cancer Tissue. J Clin. Microbiol,2004,42: 3758-376.
10[1]Ho GY,Burk RD,Klein S,et al.Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.J Natl Cancer Inst,1995,87:1365-1371.
